The U.S. electro-medical and electrotherapeutic apparatus market size was exhibited at USD 26.45 billion in 2024 and is projected to hit around USD 49.65 billion by 2034, growing at a CAGR of 6.5% during the forecast period 2024 to 2034.
Report Coverage | Details |
Market Size in 2025 | USD 28.17 Billion |
Market Size by 2034 | USD 49.65 Billion |
Growth Rate From 2024 to 2034 | CAGR of 6.5% |
Base Year | 2024 |
Forecast Period | 2024-2034 |
Segments Covered | Product, Application, End-use |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Key Companies Profiled | GE HealthCare; Koninklijke Philips N.V.;Siemens Healthineers AG; Medtronic; Abbott; Boston Scientific Corporation; Fujifilm Holdings Corporation; Zimmer Biomet; Nihon Kohden Corporation; OMRON Healthcare, Inc.; Invacare Corporation |
The country’s expanding geriatric population, an increasing focus on non-invasive and minimally invasive treatment options, and the rising prevalence of chronic diseases are key drivers for the U.S. electro-medical and electrotherapeutic apparatus industry. For instance, according to the International Agency for Research on Cancer, the U.S. saw approximately 2.38 million new cancer cases in 2022, a number expected to reach 7.85 million within the next five years. For instance, according to the International Agency for Research on Cancer, the U.S. saw approximately 2.38 million new cancer cases in 2022, a number expected to reach 7.85 million within the next five years.
The U.S. is recognized as a leader in adopting advanced healthcare technologies, which has created a highly supportive environment for the growth of the U.S. electro-medical and electrotherapeutic apparatus industry. The presence of major industry players, including both established and emerging companies, further strengthens this market. These players are continuously investing in research and development, launching innovative products, and forming strategic partnerships to meet the rising demand for high-quality, non-invasive, and minimally invasive treatments.
By introducing advanced solutions designed to improve patient outcomes and support healthcare professionals, these companies are effectively driving market expansion. These companies drive market growth by introducing advanced solutions that enhance patient outcomes and support healthcare professionals. For instance, in October 2024, GE HealthCare announced the installation of its 100th Omni Legend digital PET/CT system in the United States and Canada at the newly opened UW Health Eastpark Medical Center in Madison. Moreover, less than a year after joining Wisconsin’s BioHealth Tech Hub, GE HealthCare is strengthening the region’s personalized medicine innovation and manufacturing ecosystem by establishing the first North American production line for the system in Waukesha, Wisconsin.
The shift to modern lifestyles in the U.S. has brought changes in diet, physical activity, stress levels, and work routines, which, while adding convenience, are also linked to an increase in chronic health conditions such as diabetes, cardiovascular diseases, and respiratory disorders. For instance, according to National Association of Chronic Disease Directors, in 2022, nearly 60% of adult U.S. citizens had at least one chronic disease. This shift highlights the growing need for advanced medical solutions to manage the growing healthcare burden posed by these conditions.
In addition, there is a rising demand for innovative medical devices that facilitate early diagnosis, proactive health management, and minimally invasive treatments. With increased public awareness of chronic diseases and the advantages of advanced healthcare technologies, both patients and healthcare providers are turning to electro-medical and electrotherapeutic devices to improve patient outcomes and enhance quality of care.
Diagnostic equipment segment held the largest market share of about 38.2% in 2024. This dominance can be attributed to the rising prevalence of chronic disorders, which has led to an increased demand for advanced diagnostic tools and technologies. As chronic diseases such as cardiovascular conditions, diabetes, and cancer become more common, healthcare providers require more sophisticated and accurate diagnostic equipment to detect and manage these conditions effectively. According to the CDC, heart disease is the leading cause of death for men, women, and people across racial and ethnic groups in the U.S., with one death occurring every 33 seconds due to cardiovascular complications.
Therapeutic equipment segment is expected to grow at a fastest CAGR of 7.2% over the forecast period. Technological advancements are transforming this segment, enabling more personalized and effective therapeutic options. For instance, in February 2024, the FDA approved Boston Scientific's Spinal Cord Stimulator Systems specifically for managing non-surgical back pain.Therapeutic devices feature capabilities like customizable treatment settings, enhanced safety features, and even AI-driven adjustments based on real-time patient responses. These innovations are driving the adoption of therapeutic equipment across healthcare facilities.
The cardiology segment dominated the market by capturing a share of more than 25% in 2024. This dominance is primarily driven by the increasing prevalence of cardiovascular diseases and the growing demand for precise and effective diagnostic and therapeutic tools, which are fueling the adoption of electro-medical and electrotherapeutic devices in cardiology. In addition, market players are actively launching new products to maintain their competitive edge, often securing regulatory approvals for advanced devices. For instance, in October 2023, Medtronic received FDA approval for its extravascular defibrillator, designed to treat abnormal heart rhythms and sudden cardiac arrest.
The neurology segment is expected to grow at a CAGR over the forecast period. This is owing to the increasing incidence of neurological disorders such as stroke, epilepsy, and neurodegenerative diseases. The growing demand for advanced diagnostic tools and therapies, including brain stimulation devices, EEG monitors, and neuroimaging equipment, is propelling the market growth. In addition, innovations in neurotechnology, such as non-invasive treatments and personalized therapies, are enhancing the effectiveness of care and improving patient outcomes
Hospitals segment dominated the market with a share of nearly 46.0% in 2024, driven by the increasing adoption of advanced electro-medical and electrotherapeutic devices within hospital settings. The demand for precise, high-quality medical equipment is particularly strong in hospitals, which rely on these devices for a wide range of diagnostic, monitoring, and therapeutic applications, such as treating chronic diseases, cardiovascular conditions, and neurological disorders. In addition, the growing focus on enhancing patient outcomes through early detection, accurate diagnostics, and more effective treatment strategies is driving the widespread use of advanced technologies in hospitals.
The diagnostic imaging centers segment is anticipated to experience the fastest growth over the forecast period. These centers are becoming increasingly popular among patients due to their advanced medical equipment and the ability to provide quicker results with minimal wait times. Equipped with advanced imaging technologies such as CT scanners, MRI machines, ultrasound devices, and advanced laboratory testing tools, diagnostic imaging centers can offer accurate and efficient diagnostic services. This combination of technology and speed is driving their growing preference in the healthcare industry.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. electro-medical and electrotherapeutic apparatus market
By Product
By Application
By End-use
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End use
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.3. Competitive Insights
Chapter 3. U.S. Electro-medical and Electrotherapeutic Apparatus Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising prevalence of chronic disorders
3.4.1.2. Rising geriatric population
3.4.1.3. Growing focus on non-invasive and minimally invasive treatments
3.4.2. Market restraint analysis
3.4.2.1. High cost of advanced devices
3.4.2.2. Lack of skilled healthcare professionals
3.5. U.S. Electro-medical and Electrotherapeutic Apparatus Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
Chapter 4. U.S. Electro-medical and Electrotherapeutic Apparatus Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Electro-medical and Electrotherapeutic Apparatus Product Market Movement Analysis
4.3. U.S. Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by Product, 2021 to 2034 (USD Million)
4.4. Diagnostic Equipment
4.4.1. Diagnostic equipment market estimates and forecast 2021 to 2034 (USD Million)
4.5. Therapeutic Equipment
4.5.1. Therapeutic equipment market estimates and forecast 2021 to 2034 (USD Million)
4.6. Surgical Devices
4.6.1. Surgical devices market estimates and forecast 2021 to 2034 (USD Million)
4.7. Patient Assistive Devices
4.7.1. Patient assistive devices market estimates and forecast 2021 to 2034 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecast 2021 to 2034 (USD Million)
Chapter 5. U.S. Electro-medical and Electrotherapeutic Apparatus Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Electro-medical and Electrotherapeutic Apparatus Application Market Movement Analysis
5.3. U.S. Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by Application, 2021 to 2034 (USD Million)
5.4. Cardiology
5.4.1. Cardiology market estimates and forecasts 2021 to 2034 (USD Million)
5.5. Neurology
5.5.1. Neurology market estimates and forecasts 2021 to 2034 (USD Million)
5.6. Oncology
5.6.1. Oncology market estimates and forecasts 2021 to 2034 (USD Million)
5.7. Orthopedics
5.7.1. Orthopedics market estimates and forecasts 2021 to 2034 (USD Million)
5.8. Gynecology
5.8.1. Gynecology market estimates and forecasts 2021 to 2034 (USD Million)
5.9. Urology
5.9.1. Urology market estimates and forecasts 2021 to 2034 (USD Million)
5.10. Others
5.10.1. Others market estimates and forecasts 2021 to 2034 (USD Million)
Chapter 6. U.S. Electro-medical and Electrotherapeutic Apparatus Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Electro-medical and Electrotherapeutic Apparatus End Use Market Movement Analysis
6.3. U.S. Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by End Use, 2021 to 2034 (USD Million)
6.4. Hospitals
6.4.1. Hospitals estimates and forecast 2021 to 2034 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory surgical centers market estimates and forecast 2021 to 2034 (USD Million)
6.6. Diagnostic Centers
6.6.1. Diagnostic imaging centers market estimates and forecast 2021 to 2034 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecast 2021 to 2034 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2024
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators and Leaders
7.6. Company Profiles
7.6.1. GE HealthCare
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Koninklijke Philips N.V.
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. Siemens Healthineers AG
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Medtronic
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Abbott
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. Boston Scientific Corporation
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. Fujifilm Holdings Corporation
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Zimmer Biomet
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Nihon Kohden Corporation
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
7.6.10. OMRON Healthcare, Inc.
7.6.10.1. Company overview
7.6.10.2. Financial performance
7.6.10.3. Product benchmarking
7.6.10.4. Strategic initiatives
7.6.11. Invacare Corporation
7.6.11.1. Company overview
7.6.11.2. Financial performance
7.6.11.3. Product benchmarking
7.6.11.4. Strategic initiatives